“Clinical and economic analysis of the feasibility of using Dicarbamine® for the prevention of toxic effects of chemotherapy”, Вопр. онкол., vol. 59, no. 5, pp. 637–641, Dec. 2013, doi: 10.37469/0507-3758-2013-59-5-637-641.